Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 16 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
33 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Healis Holding from Geel, company number BE1020331023, closed financial year 2025 with a result of € 2.3 million after tax. For that financial year Healis Holding recorded revenue of € 2.4 million and equity of € 24.3 million. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 8, 2026.
€ 24.3 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2.3 million
Profit after tax over the fiscal year.
€ 125,408
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2.3 million.
People and assets in 2025
0.6
Average over the fiscal year, from the social balance sheet.
€ 105,619
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 92,235
Of which on lease € 29,623.
Debts at end 2025
€ 21.5 million
€ 1.8 million is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 502,074
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 135 days on average.
€ 55,771
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Healis Holding?
What happened at Healis Holding in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- HILDE WINDELS BV stepped down as director. NBB
- A.L.M. Management & Consulting BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.3 million. Source: NBB ↗
- HILDE WINDELS BV became a director. NBB
- A.L.M. Management & Consulting BV became a director. NBB
- New establishment in Geel. KBO
- Ilke Aerts became a director. NBB
- S.I.M.C. NV became a director. NBB
In short
Paid € 15,734 in corporate taxes since 2025.
Pays suppliers within 135 days on average.
A new publication or filing at Healis Holding? We notify you, reason included.
Follow Healis HoldingDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of WISLI INVEST, GROEP PANORAMA APOTHEKEN comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Healis HoldingBehind Healis Holding are Ilke Aerts, S.I.M.C. NV, Lieven De Marez and I & P Consulting BV. The shares are held by WISLI INVEST (45.2%) and GROEP PANORAMA APOTHEKEN. It owns 100% of Apotheek Sint Jacob, 100% of Panorama Operations, 100% of Apotheek Dessein, 100% of Apotheek Van Ghyseghem, 100% of Apotheek Roosevelt and 100% of PIERS itself.
Directors
According to the 2025 annual accounts
Ilke Aerts
Director
since 2025
Director · represented by Patrick Syen
Also active at: WHY NOT, B & S Beheer, SOM BEHEERSMAATSCHAPPIJ, VESPRO GRONDMAATSCHAPPIJ, VESPRO CONSTRUCT, Nieuwbouwwereld, PRO PLAZA INVEST, VASTGOED3 +17 more
since 2025
Lieven De Marez
Director
Also active at: APOTHEEK DESSEIN, FARMA - IMMO, VETRIA, XLENT-IMMO, SANIDUS, WISLI INVEST, LIEVEN DE MAREZ
since 2025
Director · represented by Patrick Kerkhofs
Also active at: WHY NOT, B & S Beheer, SOM BEHEERSMAATSCHAPPIJ, VESPRO GRONDMAATSCHAPPIJ, VESPRO CONSTRUCT, Nieuwbouwwereld, PRO PLAZA INVEST, VASTGOED3 +18 more
since 2025
Director · represented by Hilde Windels
Also active at: Gimv, MDxHealth, Celyad Oncology
since 2026 · until 2029
A.L.M. Management & Consulting BV
Director · represented by Ann Meulemans
Also active at: 2 BRIDGE, Aboleris Holdco
since 2026 · until 2029
Shareholders
Participations
100%
100%
100%
100%
100%
Establishments
Establishment units
Physical locations of this company
Winkelom 83B box 1
2440 Geel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 33 companies are registered at this address.
All companies at this address →BORMANSHOF
€ 32,004 gross margin · 2025
VSP Boortmeerbeek
€ 1.4 million gross margin · 2025
PROBIS
€ 4.7 million gross margin · 2025
Bestuursvereniging
Qaly Development
€ -1,973 gross margin · 2025
+28 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1020.331.023
- VAT number
- BE 1020.331.023
- Registered office
- Winkelom 83B bus 1, 2440 Geel
- Names & denominations
- Healis Holding
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 February 2025
- Peppol
- Active · Active since 2 Dec 2025
- Activities · NACE
Activiteiten van holdings
Detailhandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Groothandel in farmaceutische en medische artikelen
Detailhandel in corrigerende brillen, lenzen en zonnebrillen